Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155668 | SCV000205378 | uncertain significance | not specified | 2013-04-12 | criteria provided, single submitter | clinical testing | The Gln4162X variant in TTN has not been reported in individuals with cardiomyop athy or in large population studies. This nonsense variant creates a premature s top codon at position 4162. This variant is located in the last exon of an alter native transcript (Novex-3) and is expected to result in a truncated protein. A lthough truncating variants in the TTN gene are common in individuals with DCM ( Herman 2012), the function of the Novex-3 transcript is unclear. In summary, add itional information is needed to fully assess the clinical significance of this variant. |
Eurofins Ntd Llc |
RCV000727322 | SCV000707553 | uncertain significance | not provided | 2017-04-03 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV005404278 | SCV006068685 | uncertain significance | Cardiovascular phenotype | 2025-04-09 | criteria provided, single submitter | clinical testing |